| Pharmacy Times | All Publications

A Pharmacist's Guide to OTC Therapy: Ocular Care Products

ByYvette C. Terrie, BSPharm, RPh

October 1st 2005

Dangerous Liaisons: Schizophrenia and Diabetes

ByGuido R. Zanni, PhD,Jeannette Yeznach Wick, RPh, MBA, FASCP

October 1st 2005

A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplements

ByYvette C. Terrie, BSPharm, RPh

October 1st 2005

Tarceva Extends Lung Cancer Survival

BySusan Farley

October 1st 2005

Inhaled Morphine Aids Cancer-related Dyspnea

BySusan Farley

October 1st 2005

Diuretic Best BP Therapy for African Americans

BySusan Farley

October 1st 2005

A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Products

ByYvette C. Terrie, BSPharm, RPh

October 1st 2005

New Drug Blocks Out AIDS Virus

BySusan Farley

October 1st 2005

Viagra Ingredient Has Another Use

BySusan Farley

October 1st 2005

GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIA

ByHarvey E. Maldow, RPh, MS

October 1st 2005

Shake Well Before Dispensing

ByKate Kelly, PharmD

October 1st 2005

Predicting Interactions with PDE5 Inhibitors

ByCindy Ta, PharmD,John R. Horn, PharmD, FCCP,Philip D. Hansten, PharmD

October 1st 2005

In the Wake of Katrina, Chain Pharmaciesand Drug Companies Join Forces

ByEileen Koutnik-Fotopoulos

October 1st 2005

Pharmacy Kiosks on the Way

October 1st 2005

Coalition to Take Action Against PBMs

October 1st 2005

Pharmacy Tour Reaches Communities

October 1st 2005

Crawford Resigns as FDA Commissioner

October 1st 2005

APhA Applauds CMS Efforts

October 1st 2005

HHS Awards Grants for Mental Health Support

October 1st 2005

Incorporating MTMS in Medicare Part D

October 1st 2005

Rx Error Law Clears Congress—But Will It Work?

ByKen Rankin

October 1st 2005

Drug Chains Urge National OTC Drug Rules

ByKen Rankin

October 1st 2005

MSI Mourns Loss of Former President

October 1st 2005

Missouri Helps with Pharmacist Shortage

October 1st 2005

Prescription Drug Plan Gains Support

October 1st 2005

CMS Moves to Curb Part D Marketing

ByKen Rankin

October 1st 2005

Will a Pharmacist-Only Drug Class Cut Errors?

ByKen Rankin

October 1st 2005

Cost of Medicare Rx Benefit Drops, CMS Says

ByKen Rankin

October 1st 2005

Drug Chains Propose Steps to Cut Costs

ByKen Rankin

October 1st 2005

Pharmacists Will Get a Heads-Up on DTC Ads

ByKen Rankin

October 1st 2005

A Pharmacist's Guide to OTC Therapy: Ocular Care Products

Dangerous Liaisons: Schizophrenia and Diabetes

A Pharmacist's Guide to OTC Therapy: Diabetic Nutritional Supplements

Tarceva Extends Lung Cancer Survival

Inhaled Morphine Aids Cancer-related Dyspnea

Diuretic Best BP Therapy for African Americans

A Pharmacist's Guide to OTC Therapy: Diabetic Foot Care Products

New Drug Blocks Out AIDS Virus

Viagra Ingredient Has Another Use

GUEST COMMENTARY: FIGHTING THE NEW PHARMACOPHOBIA

Shake Well Before Dispensing

Predicting Interactions with PDE5 Inhibitors

In the Wake of Katrina, Chain Pharmaciesand Drug Companies Join Forces

Pharmacy Kiosks on the Way

Coalition to Take Action Against PBMs

Pharmacy Tour Reaches Communities

Crawford Resigns as FDA Commissioner

APhA Applauds CMS Efforts

HHS Awards Grants for Mental Health Support

Incorporating MTMS in Medicare Part D

Rx Error Law Clears Congress—But Will It Work?

Drug Chains Urge National OTC Drug Rules

MSI Mourns Loss of Former President

Missouri Helps with Pharmacist Shortage

Prescription Drug Plan Gains Support

CMS Moves to Curb Part D Marketing

Will a Pharmacist-Only Drug Class Cut Errors?

Cost of Medicare Rx Benefit Drops, CMS Says

Drug Chains Propose Steps to Cut Costs

Pharmacists Will Get a Heads-Up on DTC Ads

Trending on Pharmacy Times

CDC’s Autism Statement Sparks New Concerns Over Vaccine Safety Messaging

Patients With Long COVID Face Varying Trajectories, With Most Facing Symptoms Long After Infection

Kratom Controversies: Exploring Use and Regulation

Weight Loss Drugs On the Horizon: What Pharmacists Should Know

FDA Approves Aflibercept Injection to Treat Patients With Macular Edema Following RVO